Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

Published:2015-09-23 Issue:3 Volume:37 Page:229-240
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Sabaté Manel,Windecker Stephan,Iñiguez Andres,Okkels-Jensen Lisette,Cequier Angel,Brugaletta Salvatore,Hofma Sjoerd H.,Räber Lorenz,Christiansen Evald Høi,Suttorp Maarten,Pilgrim Thomas,Anne van Es Gerrit,Sotomi Yohei,García-García Hector M.,Onuma Yoshinobu,Serruys Patrick W.

Funder

European Cardiovascular Research Institute (ECRI)

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/37/3/229/17356853/ehv500.pdf

Reference37 articles.

1. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

2. 2014 ESC/EACTS Guidelines on myocardial revascularization

3. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial